02/14/2019
3:04 PM | Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A
|  |
02/13/2019
10:52 AM | Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
5:50 AM | Five Prime Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
02/12/2019
8:43 AM | Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/11/2019
8:29 AM | Five Prime Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/07/2019
4:24 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:21 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:18 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:14 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
3:08 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2019
5:07 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
5:10 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2018
3:10 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2018
6:21 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:10 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2018
7:32 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
8:05 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2018
3:00 PM | Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G
| |
10/04/2018
4:09 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G/A
| |
10/02/2018
5:50 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
5:46 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
5:43 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2018
11:12 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2018
11:58 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
11:29 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2018
11:57 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2018
2:46 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2018
12:45 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
12:05 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
12:03 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
12:00 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
10:27 AM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
10:24 AM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
10:22 AM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2018
4:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G
| |
08/28/2018
9:06 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2018
2:33 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2018
1:38 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2018
11:54 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2018
12:18 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2018
2:18 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
6:49 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
3:16 PM | Five Prime Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2018
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2018
7:16 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2018
12:09 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2018
5:07 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2018
7:26 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
7:23 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
7:21 PM | Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
7:18 PM | Five Prime Therapeutics (Issuer)
MCDADE MARK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
7:15 PM | Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
6:47 PM | Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
5:51 PM | BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
5:47 PM | Five Prime Therapeutics (Issuer)
Gujrathi Sheila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2018
3:06 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2018
3:23 PM | Five Prime Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/08/2018
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2018
12:29 PM | Five Prime Therapeutics (Issuer)
Rubinstein Linda M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2018
3:06 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2018
11:43 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2018
3:05 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/30/2018
5:03 AM | Five Prime Therapeutics (Filer)
| Form DEF 14A
| |
03/22/2018
1:50 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2018
6:32 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
6:29 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
6:26 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
6:24 PM | Belsky Marc (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
6:23 PM | Baker Kevin Paul (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
6:18 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
6:16 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 3/A
| |
02/28/2018
6:15 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2018
3:10 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
6:24 AM | Five Prime Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/13/2018
10:46 AM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4/A
| |
02/13/2018
10:36 AM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4/A
| |
02/09/2018
5:40 AM | Five Prime Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/08/2018
10:37 AM | Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/07/2018
1:19 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2018
1:15 PM | Belsky Marc (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2018
1:05 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2018
1:03 PM | Baker Kevin Paul (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2018
2:13 PM | Baker Kevin Paul (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2018
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2018
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2018
3:04 PM | Five Prime Therapeutics (Filer)
| Form 424B5
| |
01/23/2018
4:01 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2018
3:03 PM | Five Prime Therapeutics (Filer)
| Form 424B5
| |
12/19/2017
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2017
6:19 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
